AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test - PubMed (original) (raw)
AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test
Todd D Gould et al. Int J Neuropsychopharmacol. 2004 Dec.
Free article
Abstract
The mechanism by which lithium exerts either its anti-manic or antidepressant effects remains to be fully elucidated. Although lithium inhibits the enzyme glycogen synthase kinase-3 (GSK-3) at concentrations that are relevant for treatment of bipolar disorder, it is unclear whether GSK-3-related mechanisms are responsible for its therapeutic effects in the treatment of this disease. We report that AR-A014418 (a selective GSK-3 inhibitor) induces behavioural changes that are consistent with the effects of antidepressant medications. Subacute intraperitoneal injections of AR-A014418 reduced immobility time in rats exposed to the forced swim test, a well-established model for antidepressant efficacy. In addition, the specificity of this effect is supported by our finding that AR-A014418 decreased spontaneous as well as amphetamine-induced activity. Taken together, these data support the hypothesis that lithium may exert its antidepressant effects through inhibition of GSK-3, and that novel small-molecule GSK-3 inhibitors may be useful for the treatment of bipolar disorder and depression.
Similar articles
- Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
Rosa AO, Kaster MP, Binfaré RW, Morales S, Martín-Aparicio E, Navarro-Rico ML, Martinez A, Medina M, García AG, López MG, Rodrigues AL. Rosa AO, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1549-56. doi: 10.1016/j.pnpbp.2008.05.020. Epub 2008 Jun 25. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18579278 - Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action.
Mazzardo-Martins L, Martins DF, Stramosk J, Cidral-Filho FJ, Santos AR. Mazzardo-Martins L, et al. Neuroscience. 2012 Dec 13;226:411-20. doi: 10.1016/j.neuroscience.2012.09.020. Epub 2012 Sep 19. Neuroscience. 2012. PMID: 23000630 - Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS, Dal-Pont GC, Resende WR, Jornada LK, Peterle BR, Machado AG, Farias HR, de Souza CT, Carvalho AF, Quevedo J. Valvassori SS, et al. Neuropharmacology. 2017 May 1;117:447-459. doi: 10.1016/j.neuropharm.2016.10.015. Epub 2016 Oct 24. Neuropharmacology. 2017. PMID: 27789311 - Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders.
Gould TD, Picchini AM, Einat H, Manji HK. Gould TD, et al. Curr Drug Targets. 2006 Nov;7(11):1399-409. doi: 10.2174/1389450110607011399. Curr Drug Targets. 2006. PMID: 17100580 Review. - Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
Gould TD, Manji HK. Gould TD, et al. Neuropsychopharmacology. 2005 Jul;30(7):1223-37. doi: 10.1038/sj.npp.1300731. Neuropsychopharmacology. 2005. PMID: 15827567 Review.
Cited by
- Effect of Imipramine, Paroxetine, and Lithium Carbonate on Neurobehavioral Changes of Streptozotocin in Rats: Impact on Glycogen Synthase Kinase-3 and Blood Glucose Level.
Nadeem RI, Ahmed HI, El-Denshary EE. Nadeem RI, et al. Neurochem Res. 2015 Sep;40(9):1810-8. doi: 10.1007/s11064-015-1670-6. Epub 2015 Jul 28. Neurochem Res. 2015. PMID: 26216050 - The wnt pathway in mood disorders.
Sani G, Napoletano F, Forte AM, Kotzalidis GD, Panaccione I, Porfiri GM, Simonetti A, Caloro M, Girardi N, Telesforo CL, Serra G, Romano S, Manfredi G, Savoja V, Tamorri SM, Koukopoulos AE, Serata D, Rapinesi C, Del Casale A, Nicoletti F, Girardi P. Sani G, et al. Curr Neuropharmacol. 2012 Sep;10(3):239-53. doi: 10.2174/157015912803217279. Curr Neuropharmacol. 2012. PMID: 23449817 Free PMC article. - Increased glycogen synthase kinase-3β mRNA level in the hippocampus of patients with major depression: a study using the stanley neuropathology consortium integrative database.
Oh DH, Park YC, Kim SH. Oh DH, et al. Psychiatry Investig. 2010 Sep;7(3):202-7. doi: 10.4306/pi.2010.7.3.202. Epub 2010 Jul 12. Psychiatry Investig. 2010. PMID: 20927309 Free PMC article. - Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus.
Yoshida S, Maeda M, Kaku S, Ikeya H, Yamada K, Nakaike S. Yoshida S, et al. J Neural Transm (Vienna). 2006 Nov;113(11):1803-14. doi: 10.1007/s00702-006-0528-0. Epub 2006 Jul 20. J Neural Transm (Vienna). 2006. PMID: 16855914 - Neuronal apoptosis and motor deficits in mice with genetic inhibition of GSK-3 are Fas-dependent.
Gómez-Sintes R, Lucas JJ. Gómez-Sintes R, et al. PLoS One. 2013 Aug 5;8(8):e70952. doi: 10.1371/journal.pone.0070952. Print 2013. PLoS One. 2013. PMID: 23940673 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials